Literature DB >> 23613634

Effect of Helicobacter pylori eradication on serum ghrelin and obestatin levels.

Celal Ulasoglu1, Banu Isbilen, Levent Doganay, Filiz Ozen, Safak Kiziltas, Ilyas Tuncer.   

Abstract

AIM: To investigate changes in serum ghrelin and obestatin levels before and after Helicobacter pylori (H. pylori) eradication.
METHODS: A total of 92 patients presenting with symptoms of dyspepsia were enrolled in the study. Upper endoscopy was performed on all patients and used to diagnose H. pylori infection according to the presence of characteristic histopathological findings; seventy patients were diagnosed with H. pylori infection and the remaining 22 non-infected patients were classified as healthy controls. H. pylori eradication was accomplished by administering the classical triple therapy drug regimen, consisting of lansoprazole 30 mg bid, amoxicillin 1 g bid, and clarithromycin 500 mg tid for 14 d. The eradication of H. pylori was assessed with C¹⁴-urea breath test, which was performed at eight weeks after treatment. Levels of serum active ghrelin and obestatin were assessed at beginning of the study (prior to treatment) and after eight weeks. The levels were comparatively analyzed between the H. pylori negative control group, the H. pylori eradicated group, and the H. pylori non-eradicated group.
RESULTS: A total of 92 patients, 50 females and 42 males with a mean age of 38.2 ± 11.9 years (range: 19-64), were analyzed. H. pylori eradication success was achieved in 74.3% (52/70) of H. pylori positive patients. The initial levels of ghrelin in the H. pylori positive and control cases were 63.6 ± 19.8 pg/mL and 65.1 ± 19.2 pg/mL (P = 0.78), respectively, and initial obestatin levels were 771 ± 427 pg/mL and 830 ± 296 pg/mL (P = 0.19), respectively. The difference between the initial levels and the week 8 levels of ghrelin and obestatin in the control group was insignificant [4.5% (P = 0.30) and -0.9% (P = 0.65), respectively]. The difference between the initial and week 8 levels of ghrelin and obestatin in the H. pylori non-eradicated group were also insignificant [0.9% (P = 0.64) and 5.3% (P = 0.32), respectively]. The H. pylori eradicated group had a greater change in obestatin levels when compared to the control and the non-eradicated groups (148 ± 381 pg/mL vs -12 ± 138 pg/mL and -72.8 ± 203 pg/mL, respectively, P = 0.015), while decreases in ghrelin levels were insignificant (-7.2 pg/mL vs -1.4 pg/mL and -1.9 pg/mL, respectively, P = 0.52). The ghrelin/obestatin ratio for the initial and week 8 levels changed significantly in only the H. pylori eradicated group (0.11 vs 0.08, respectively, P = 0.015). For overweight patients (as designated by body mass index), we observed significant increases in obestatin levels in the eradicated group as compared to non-eradicated group (201 ± 458 pg/mL vs -5 ± 81 pg/mL, respectively, P = 0.02). In the H. pylori-eradicated group, the levels did not differ between the sexes for ghrelin (-6.3 ± 26.9 pg/mL vs -8.0 ± 24.0 pg/mL, respectively, P = 0.97) or obestatin (210 ± 390 pg/mL vs 96 ± 372 pg/mL, respectively, P = 0.23).
CONCLUSION: Serum levels of ghrelin decreased while obestatin levels increased in H. pylori eradicated subjects, especially in overweight and male patients.

Entities:  

Keywords:  Appetite; Gastric peptides; Ghrelin; Helicobacter pylori; Obestatin

Mesh:

Substances:

Year:  2013        PMID: 23613634      PMCID: PMC3631992          DOI: 10.3748/wjg.v19.i15.2388

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.

Authors:  Angelo DelParigi; Matthias Tschöp; Mark L Heiman; Arline D Salbe; Barbora Vozarova; Susan M Sell; Joy C Bunt; P Antonio Tataranni
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Evaluation of the comparability of commercial ghrelin assays.

Authors:  Michael Gröschl; Manfred Uhr; Thomas Kraus
Journal:  Clin Chem       Date:  2004-02       Impact factor: 8.327

3.  Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples.

Authors:  Hiroshi Hosoda; Kentaro Doi; Noritoshi Nagaya; Hiroyuki Okumura; Eiichiro Nakagawa; Mitsunobu Enomoto; Fumiaki Ono; Kenji Kangawa
Journal:  Clin Chem       Date:  2004-06       Impact factor: 8.327

4.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

5.  Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats.

Authors:  Virginie Tolle; Marie-Helene Bassant; Philippe Zizzari; Frederique Poindessous-Jazat; Catherine Tomasetto; Jacques Epelbaum; Marie-Therese Bluet-Pajot
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

6.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

Authors:  H Ariyasu; K Takaya; T Tagami; Y Ogawa; K Hosoda; T Akamizu; M Suda; T Koh; K Natsui; S Toyooka; G Shirakami; T Usui; A Shimatsu; K Doi; H Hosoda; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

7.  Hyperthyroidism is associated with suppressed circulating ghrelin levels.

Authors:  Anne Lene Dalkjaer Riis; Troels Krarup Hansen; Niels Møller; Jørgen Weeke; Jens Otto Lunde Jørgensen
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

8.  Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones.

Authors:  Mary Jane De Souza; Heather J Leidy; Emma O'Donnell; Bill Lasley; Nancy I Williams
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

9.  Plasma ghrelin following cure of Helicobacter pylori.

Authors:  C U Nwokolo; D A Freshwater; P O'Hare; H S Randeva
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 10.  Influence of ghrelin on energy balance and endocrine physiology.

Authors:  Hanna Komarowska; Magdalena Jaskula; Adam Stangierski; Ryszard Wasko; Jerzy Sowinski; Marek Ruchala
Journal:  Neuro Endocrinol Lett       Date:  2012       Impact factor: 0.765

View more
  9 in total

1.  Helicobacter pylori infection and serum leptin, obestatin, and ghrelin levels in Mexican schoolchildren.

Authors:  Carolina Romo-González; Eugenia Mendoza; Robertino M Mera; Rafael Coria-Jiménez; Patricia Chico-Aldama; Rita Gomez-Diaz; Ximena Duque
Journal:  Pediatr Res       Date:  2017-06-14       Impact factor: 3.756

2.  Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.

Authors:  Orhan Sezgin; Mehmet Kasım Aydın; Asena Ayça Özdemir; Arzu Emine Kanık
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

Review 3.  Diverse and Complementary Effects of Ghrelin and Obestatin.

Authors:  Daniel Villarreal; Geetali Pradhan; Yu Zhou; Bingzhong Xue; Yuxiang Sun
Journal:  Biomolecules       Date:  2022-03-29

Review 4.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

5.  Changes in Metabolic Hormones in Malaysian Young Adults following Helicobacter pylori Eradication.

Authors:  Theresa Wan-Chen Yap; Alex Hwong-Ruey Leow; Ahmad Najib Azmi; Fritz Francois; Guillermo I Perez-Perez; Martin J Blaser; Bee-Hoon Poh; Mun-Fai Loke; Khean-Lee Goh; Jamuna Vadivelu
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

6.  Plasma ghrelin level and plasma ghrelin/obestatin ratio are related to intestinal metaplasia in elderly patients with functional dyspepsia.

Authors:  Su Hwan Kim; Ji Won Kim; Junsu Byun; Ji Bong Jeong; Byeong Gwan Kim; Kook Lae Lee
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

7.  Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass.

Authors:  Myong Ki Baeg; Myung-Gyu Choi; Sun-Hye Ko; Chul-Hyun Lim; Jin Su Kim; Yu Kyung Cho; Jae Myung Park; Young-Seok Cho; Bo-In Lee; In-Seok Lee
Journal:  Clin Interv Aging       Date:  2015-10-30       Impact factor: 4.458

8.  Helicobacter pylori and corpus gastric pathology are associated with lower serum ghrelin.

Authors:  Paula Mantero; Gonzalo Sebastián Matus; Rodolfo Ernesto Corti; Ana María Cabanne; Gerardo Gabriel Zerbetto de Palma; Liliana Marchesi Olid; María Marta Piskorz; Marcela Beatriz Zubillaga; Mariana Andrea Janjetic; Cinthia Gabriela Goldman
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

9.  Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection.

Authors:  Paulina Konrad; Jan Chojnacki; Anita Gąsiorowska; Cezary Rudnicki; Aleksandra Kaczka; Cezary Chojnacki
Journal:  Prz Gastroenterol       Date:  2018-03-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.